Zalypsis Has Synergistic Effect When Combined with Bortezomib + Dexamethasone through Caspase Dependent and Mainly Independent Mechanisms and through A Potent Induction of DNA Damage

E. Ocio,Lorena González-Coco,L. San-Segundo,X. K. Chen,Teresa Hernández-Iglesias,Diego Fernández-Lázaro,T. Paíno,M. Garayoa,C. Cuevas,P. Avilés,E. Álava,A. Pandiella,J. Miguel

Published 2010 in Blood

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2010
Venue
Blood
Publication date
2010-11-19
Fields of study
Medicine
Identifiers
DOI 10.1182/BLOOD.V116.21.3003.3003
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

Phase I/II study of weekly PM00104 (Zalypsis®) in patients with relapsed/refractory multiple myeloma
2016cites this paper